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Background: Pulmonary complications are well-described sequelae of cardiac surgery. Further, optimization of lung disease prior to surgery is 
known to improve outcomes. However, there is no standardized assessment of lung function performed as part of the pre-operative evaluation. This 
study hypothesized that pulmonary disease is currently underdiagnosed and undertreated in patients being evaluated for cardiac surgery, resulting in 
suboptimal outcomes.
Methods: A retrospective cohort of 959 consecutive patients who underwent minimally invasive cardiac surgery between January 2005 and 
June 2011 at Columbia University was identified. Only patients undergoing minimally invasive surgery were included, in order to lessen potential 
confounding by differences in intubation times of standard versus minimally invasive approaches.
Results: Of 959 patients, 17 remained intubated for non-pulmonary reasons (need for re-operation, tracheal injury with intubation, or abdominal 
compartment syndrome) and were excluded. Of the 942 included patients, subtypes of active lung disease were compared against each other, 
and no significant difference was detected. Patients with non-optimized lung disease (active smoking, pneumonia, or COPD exacerbations) were 
then compared to those with treated lung disease. No significant demographic differences were observed. Length of stay (LOS), intubation time 
and 30-day mortality were significantly increased in the uncontrolled group (p= <0.001, <0.001 and 0.004 respectively.) Finally, active smokers 
were compared to smokers who had quit >2 months prior to surgery. Between these demographically similar groups, LOS and intubation time 
were significantly longer in the active smokers (p= <0.001 and <0.001 respectively). 30-day mortality was also increased with p=0.003, OR=6.78 
(95%CI=1.619).
Conclusion: Patients with any non-optimized pulmonary disease are at increased risk of post-operative pulmonary complications. Cardiologists 
and cardiac surgeons evaluating patients for surgery need to adopt standardized methods of identifying and obtaining treatment for lung disease 
prior to cardiac surgery in order to improve patient outcomes.
